Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

15.4%

2 terminated/withdrawn out of 13 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

15%

2 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2
2(28.6%)
Phase 1
2(28.6%)
Phase 4
1(14.3%)
N/A
1(14.3%)
Phase 3
1(14.3%)
7Total
Phase 2(2)
Phase 1(2)
Phase 4(1)
N/A(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (13)

Showing 13 of 13 trials
NCT04031872Phase 1Withdrawn

LY3200882 and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (EORTC1615)

Role: collaborator

NCT03482362Phase 2Completed

Vinorelbine in Advanced BRAF-like Colon Cancer

Role: collaborator

NCT06884631Recruiting

Metabolic Exercise Test Data Combined with Cardiac and Kidney Indexes (MECKI) Score Evolution: Identification of Cardiovascular Risk in Patients with Heart Failure

Role: collaborator

NCT03359538Phase 2Completed

Rapamycin Treatment for ALS

Role: collaborator

NCT06530472Enrolling By Invitation

The Relationship Between Belief, Expectation, and Adherence to Therapy During COVID-19 Pandemic

Role: collaborator

NCT05769686Completed

Laparoscopic Donor Nephrectomy Score, a New Scoring System for Preoperative Prediction of Difficulty of Laparoscopic Donor Nephrectomy

Role: collaborator

NCT04434417Completed

Validation of an Immunochromatographic Assay for IgG/IgM Antibodies to 2019- nCoV

Role: collaborator

NCT03470350Phase 1Withdrawn

Galunisertib and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer

Role: collaborator

NCT03858088Completed

Early Allograft Failure Simplified Estimation (EASE) in Liver Transplantation

Role: collaborator

NCT03498664Not ApplicableUnknown

EMR-C VS EMR-S in Colonic Lateral Spreading Tumors Treatment (LST)

Role: collaborator

NCT01411579Completed

Use of DwI-MR to Predict Chemotherapy Response of Liver Metastases and Hepatocarcinoma

Role: collaborator

NCT01360346Phase 3Unknown

Enteral Versus Intravenous Sedation in Critically Ill High-risk ICU Patients

Role: collaborator

NCT01158846Phase 4Unknown

Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMI

Role: collaborator

All 13 trials loaded